Investors

Analyst Coverage

FirmAnalystE-Mail
Maxim GroupJason Kolbert jkolbert@maximgrp.com
Zacks Investment ResearchDavid Bautzdbautz@zacks.com
Brainstorm Cell Therapeutics Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Brainstorm Cell Therapeutics Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Brainstorm Cell Therapeutics Inc. or its management. Brainstorm Cell Therapeutics Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.